Suraksha Diagnostic Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has filed a disclosure with the stock exchange under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation typically pertains to reporting changes in encumbrance (pledge) on shares held by promoters or persons acting in concert. The announcement confirms that the filing has been submitted but does not provide specific details such as the nature of the encumbrance (creation, release, or invocation), the number of shares involved, or the percentage of promoter holding affected. Investors would need to refer to the actual disclosure document on the exchange website for granular details.
This is a routine regulatory compliance filing and is not necessarily negative. However, depending on the content of the disclosure (e.g., creation of a new pledge or invocation of an existing pledge), it could affect promoter shareholding visibility. Shareholders should review the detailed disclosure to understand if there is any change in the pledged status of promoter shares.